rosacea cause articles ↓
March 9th, 2011, by David Pascoe | galderma, oracea, rosacea cause
Seemingly wanting to help answer the question How do tetracyclines help Rosacea? Galderma has announced a large trial to measure the changes in inflammatory pathway markers when you take Oracea.
Whilst the trial only directly mentions LL-37 and MMP I would expect other well known markers to be measured as well.
If the researchers include markers that can be proven to be indicative of rosacea disease, …
February 2nd, 2011, by David Pascoe | neurogenic rosacea, rosacea cause
A just-published paper in the Archives of Dermatology is calling for the recognition of a new rosacea subtype – Neurogenic Rosacea.
Standard forms of rosacea
In 2002 the National Rosacea Society sponsored Rosacea Expert Committee proposed the existence of 4 main rosacea subtypes. Rosacea sufferers are familiar with the designations of Erythematotelangiectatic, Papulopustular, Phymatous and Ocular Rosacea. The subtypes were based on …
December 10th, 2010, by David Pascoe | demodex mites, research, rosacea cause
This abstract promises to tell us everything we need to know about the possible role of micro-organisms in the way that the disease Rosacea starts and develops. Even though the role of published research is not to provide reading material for the general public, I still look to journal …
December 6th, 2010, by David Pascoe | rosacea cause
Thanks for the tip from Dan, here is an interesting presentation from the AAD Summer Academy Meeting, August 4-8, Chicago, Ill. The notes are titled Acne and Rosacea: Inflammatory mechanisms and their impact on therapy and were part of Symposium S012. The Symposium was titled What’s Breaking Out: Acne and Rosacea. Dr. Bhatia was the first speaker, and was down to cover this …
November 30th, 2010, by David Pascoe | finacea, research, rosacea cause
Following on from a study that was able to show the reason that Finacea was able to adjust the inflammatory response in the skin, is this JAAD Poster session abstract. This paper is looking at how the active ingredient in Finacea, azelaic acid can decrease the expression of 2 substances thought to be important in rosacea – kallikrein 5 (KLK5) and …